Patents by Inventor Roger Appelqvist

Roger Appelqvist has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230414726
    Abstract: A respirable aqueous pharmaceutical composition comprising a neutralizing affinity binder for a virus binding to angiotensin-converting enzyme 2 (ACE2), a buffer, and a solubilizer.
    Type: Application
    Filed: November 9, 2021
    Publication date: December 28, 2023
    Inventors: György MARKO-VARGA, Yutaka SUGIHARA, Jeovanis GIL VALDÉS, Roger APPELQVIST, Johan MALM
  • Publication number: 20230151077
    Abstract: In the invention is provided a polypeptide comprising at least 75 amino acids and having an amino acid sequence having at least 90%, such as at least 95%, 96%, 97, 98%, or 99%, such as 100% sequence identity (% SI) with human Angiotensin-converting enzyme 2 (ACE2) (SEQ ID NO 1), for use in the treatment of COVID19, SARS, or MERS, characterized in that the polypeptide is administered pulmonary and/or nasally. Further is provided the polypeptide for use in reducing the number of active virus particles being exhaled by a treated subject infected by SARS-CoV-2, SARS-CoV, or Mers-CoV. Also a dry powder or an aerosol comprising the polypeptide.
    Type: Application
    Filed: April 9, 2021
    Publication date: May 18, 2023
    Inventors: György MARKO-VARGA, Balazs DÖME, Viktoria LASZLO, Peter DÖME, Yutaka SUGIHARA, Jeovanis GIL VALDES, Roger APPELQVIST, Johan MALM
  • Patent number: D480241
    Type: Grant
    Filed: May 7, 2001
    Date of Patent: October 7, 2003
    Assignee: Autoadapt-Bev AB
    Inventor: Roger Appelqvist